Home
>
National Drug Code (NDC)
>
Lamisil AT
Lamisil AT - 0067-8100-30 - (Terbinafine Hydrochloride)
Drug Information of Lamisil AT
| Product NDC: | 0067-8100 |
| Proprietary Name: | Lamisil AT |
| Non Proprietary Name: | Terbinafine Hydrochloride |
| Active Ingredient(s): | 1 g/100g & nbsp; Terbinafine Hydrochloride |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | CREAM |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Lamisil AT
| Product NDC: | 0067-8100 |
| Labeler Name: | Novartis Consumer Health, Inc. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | ANDA077511 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20070702 |
Package Information of Lamisil AT
| Package NDC: | 0067-8100-30 |
| Package Description: | 1 TUBE in 1 CARTON (0067-8100-30) > 30 g in 1 TUBE |
NDC Information of Lamisil AT
| NDC Code | 0067-8100-30 |
| Proprietary Name | Lamisil AT |
| Package Description | 1 TUBE in 1 CARTON (0067-8100-30) > 30 g in 1 TUBE |
| Product NDC | 0067-8100 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Terbinafine Hydrochloride |
| Dosage Form Name | CREAM |
| Route Name | TOPICAL |
| Start Marketing Date | 20070702 |
| Marketing Category Name | ANDA |
| Labeler Name | Novartis Consumer Health, Inc. |
| Substance Name | TERBINAFINE HYDROCHLORIDE |
| Strength Number | 1 |
| Strength Unit | g/100g |
| Pharmaceutical Classes |
